ANTI-CANCER DRUGS

Journal Title

ANTI-CANCER DRUGS

ANTI-CANCER DRUG

ISSN / eISSN

0959-4973 / 1473-5741

Aims and Scope

Anti-Cancer Drugs reports both clinical and experimental results related to anti-cancer drugs, and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation. An internationally refereed journal devoted to the fast publication of innovative investigations on therapeutic agents against cancer, Anti-Cancer Drugs aims to stimulate and report research on both toxic and non-toxic anti-cancer agents. Consequently, the scope on the journal will cover both conventional cytotoxic chemotherapy and hormonal or biological response modalities such as interleukins and immunotherapy. Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editors and those invited to do so from a reviewer pool.

Subject Area

ONCOLOGY

PHARMACOLOGY & PHARMACY

CiteScore

3.40 View Trend

CiteScore Ranking

Category	Quartile	Rank
Medicine - Pharmacology (medical)	Q3	#136/260
Medicine - Oncology	Q3	#217/366
Medicine - Pharmacology	Q3	#185/301
Medicine - Cancer Research	Q3	#159/214

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
ONCOLOGY - SCIE	Q4
PHARMACOLOGY & PHARMACY - SCIE	Q3

H-index

88

Country/Area of Publication

UNITED STATES

Publisher

Lippincott Williams and Wilkins Ltd.

Publication Frequency

Monthly

Year Publication Started

1990

Annual Article Volume

241

Open Access

NO

Contact

LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621